$66.33
0.350.53%
At close: -
$66.33
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
ANI Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ANIP | Benzinga
ANI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$0.200
Quarterly Revenue Estimate
$164.66M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$614.38M
Analyze the earnings history of ANI Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ANIP | ANI Pharmaceuticals | $1.21 | $0.20 | — | — | $137.43M | $164.66M | — | — | 05/09/2025 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.00 | $0.29 | $1.63 | 462.07% | $131.65M | $175.35M | $190.57M | 8.68% | 02/28/2025 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.27 | $1.09 | $1.34 | 22.94% | $131.83M | $144.35M | $148.33M | 2.76% | 11/08/2024 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.28 | $0.94 | $1.02 | 8.51% | $116.55M | $128.62M | $138.04M | 7.32% | 08/06/2024 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.17 | $0.99 | $1.21 | 22.22% | $106.79M | $125.52M | $137.43M | 9.49% | 05/10/2024 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.76 | $0.85 | $1.00 | 17.65% | $94.23M | $122.21M | $131.65M | 7.73% | 02/29/2024 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.64 | $0.84 | $1.27 | 51.19% | $83.82M | $111.92M | $131.83M | 17.79% | 11/08/2023 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.13 | $0.68 | $1.28 | 88.24% | $73.86M | $98.70M | $116.55M | 18.08% | 08/09/2023 | Get Alert |
| ANIP | ANI Pharmaceuticals | -$0.12 | $0.35 | $1.17 | 234.29% | $64.48M | $83.49M | $106.79M | 27.90% | 05/08/2023 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.54 | $0.67 | $0.76 | 13.43% | $60.93M | $86.14M | $94.23M | 9.39% | 03/09/2023 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.01 | $0.55 | $0.64 | 16.36% | $52.06M | $78.16M | $83.82M | 7.24% | 11/09/2022 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.67 | $0.22 | $0.13 | -40.91% | $48.63M | $72.10M | $73.86M | 2.43% | 08/08/2022 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.04 | $0.09 | -$0.12 | -233.33% | $54.52M | $65.03M | $64.48M | -0.85% | 05/10/2022 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.80 | $0.74 | $0.54 | -27.03% | $57.25M | $56.30M | $60.93M | 8.22% | 03/15/2022 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.97 | $0.70 | $1.01 | 44.29% | $52.98M | $49.70M | $52.06M | 4.75% | 11/01/2021 | Get Alert |
| ANIP | ANI Pharmaceuticals | $0.69 | $0.68 | $0.67 | -1.47% | $48.47M | $48.05M | $48.63M | 1.20% | 08/06/2021 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.04 | $0.71 | $1.04 | 46.48% | $49.77M | $46.80M | $54.52M | 16.50% | 05/07/2021 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.08 | $0.94 | $0.80 | -14.89% | $47.97M | $54.27M | $57.25M | 5.49% | 03/09/2021 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.23 | $0.88 | $0.97 | 10.23% | $51.34M | $51.50M | $52.98M | 2.87% | 11/05/2020 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.44 | $1.00 | $0.69 | -31.00% | $54.36M | $48.93M | $48.47M | -0.94% | 08/06/2020 | Get Alert |
| ANIP | ANI Pharmaceuticals | $1.30 | $0.89 | $1.04 | 16.85% | $52.89M | $50.23M | $49.77M | -0.91% | 05/07/2020 | Get Alert |
ANI Pharmaceuticals (ANIP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $1.63 | $0.29 | 462.1 % |
| Q3 | 2024-11-08 | $1.34 | $1.09 | 22.9 % |
| Q2 | 2024-08-06 | $1.02 | $0.94 | 8.51 % |
| Q1 | 2024-05-10 | $1.21 | $0.99 | 22.2 % |
ANI Pharmaceuticals (ANIP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-28 | $190.57M | $175.35M | 8.68 % |
| Q3 | 2024-11-08 | $148.33M | $144.35M | 2.76 % |
| Q2 | 2024-08-06 | $138.04M | $128.62M | 7.32 % |
| Q1 | 2024-05-10 | $137.43M | $125.52M | 9.49 % |
FAQ
When is ANI Pharmaceuticals (NASDAQ:ANIP) reporting earnings?
ANI Pharmaceuticals (ANIP) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on February 28, 2025 for Q4.
What were the latest earnings per share (EPS) for ANI Pharmaceuticals (NASDAQ:ANIP)?
The Actual EPS was $1.63, which beat the estimate of $0.29.
What were ANI Pharmaceuticals’s (NASDAQ:ANIP) revenues?
The Actual Revenue was $190.6M, which beat the estimate of $175.3M.
Browse earnings estimates, EPS, and revenue on all stocks.